Dr Richard Hubner

Dr Hubner undertook preclinical medical studies at Cambridge University gaining a triple 1st class degree and clinical medical studies at Oxford University. He completed general medical training at the University Hospitals of Newcastle including gaining membership of the Royal College of Physicians. Dr Hubner subsequently spent 8 years at the Royal Marsden Hospital, London undertaking specialist medical oncology training.

As part of this specialist training he completed a PhD in genetic susceptibility to cancer. He has been a consultant medical oncologist at the Christie Hospital, Manchester since October 2010. Dr Hubner's clinical interests include systemic chemotherapies, antibody therapies, and biological therapies for cancers of the oesophagus, stomach, pancreas, bile duct, gallbladder, primary liver and neuroendocrine system. He has a strong focus on research and is involved in a portfolio of clinical trials in both early and advanced cancer settings.

Dr Hubner is particularly interested in identification of factors which predict for efficacy and toxicity of chemotherapy and other systemic therapies, with the ultimate goal of personalised anti-cancer treatment. Dr Hubner has published over 30 original research articles, review articles, book chapters and meeting abstracts.

• Systemic chemotherapies
• Antibody therapies
• Biological therapies for cancers of the oesophagus, stomach, pancreas, bile duct, gallbladder, primary liver and neuroendocrine system
• Clinical trials of novel anticancer agents

• General Medical Council
• Royal College of Physicians Association of Cancer Physicians
• British Association of Cancer Research
• American Society of Clinical Oncology